Latest news, reports, and more from the RedChip Nation.
 
Discovering Tomorrow's Blue Chips Today
April 22, 2021     Contact    
Featured This Week
 
Bragg Gaming: Technology Infrastructure for the Global Gaming Industry
 

 


Bragg Gaming (OTCQX: BRGGF) has built a strong foundation to accelerate its expansion into the burgeoning U.S. and Canadian markets. The Company is increasing its investment in its technology, regulatory/compliance and business development teams to ensure that it is optimally positioned to capture new U.S. and Canadian revenue streams. Bragg intends to launch their cutting-edge B2B iGaming technology platform and casino content aggregator in all states that permit iGaming, with the intent of building a leadership position in the B2B space. The Company is currently in the process of applying for B2B supplier licenses in New York and New Jersey, as well as multiple European jurisdictions. Revenue for FY20 was ahead of management expectations with adjusted EBITDA expected to hit the higher end of the range, while the outlook for FY21 is C$73.5M with adjusted EBITDA of C$6.4M. Visit BRGGFinfo.com to learn more.

 
 >
Latest News
 
Greenwich LifeSciences (NASDAQ: GLSI) Presents Phase IIb Poster, Published April 10th at 2021 AACR Annual Meeting, Showing GP2 Immune Response Peaked at 6 Months, Resulting in 100% Disease Free Survival from Recurring Breast Cancer
 >
Annovis Bio (NYSE American: ANVS) Appoints Reid McCarthy to Board and to Role of Audit Committee Chairman
 >
1847 Goedeker (NYSE American: GOED) and Appliances Connection Report March Orders up 106% and 110% Respectively
 
 
Tiziana Life Sciences (NASDAQ: TLSA) Announces Plans to List Accustem Sciences Limited in the U.S.
 
 
Amesite (NASDAQ: AMST) Announces Contract for Pilot Program with the EWIE Group of Companies, A Global Leader in Commodity and Chemical Management Services for the Automotive and Other Industries
 
 
Nemaura Medical (NASDAQ: NMRD) Launches BEAT diabetes Smartphone App on Android and iOS Platforms; Begins Pilot Distribution of proBEAT Sensors
 
 
COMSovereign (NASDAQ COMS) Expands its Advanced Wireless Signal Processing Capabilities with the Acquisition of Innovation Digital, LLC
 
 
Genetic Technologies (NASDAQ: GENE) Appoints Mike Tonroe as CFO
 
 
American Resources (NASDAQ: AREC) to Present at the H.C. Wainwright Spring Mining Conference
 
 
Hoth Therapeutics (NASDAQ: HOTH) Completes HT-001 Formulation Development for Upcoming Cancer Patient Clinical Trial
 
 
Esports Entertainment Group’s (NASDAQ: GMBL) ggCircuit Announces Crypto Mining Application for LAN Centers
 
 
SPI Energy (NASDAQ: SPI) Executes Agreement to Acquire 6.5MW Solar PV and 5.45MWh Energy Storage Project in Massachusetts
 
 
Medalist Diversified REIT (NASDAQ: MDRR) Announces Series A Preferred Stock Cash Dividend
 
 
RYU Apparel (OTC: RYPPF) Provides Shareholder Update from CEO
 
 
DSG Global (OTCQB: DSGT) and Imperium Motors Corp. announce shipping updates on Jonway LSV's, Rover e-Bikes, Skywell Bus and Terra Truck Products
 
 
CBD of Denver (OTC: CBDD) Reports Highest Single-Day Sales Since Start of Switzerland's COVID-19 Lockdowns
 
 
Red Cat Holdings (OTCQB: RCAT) Announces Issuance of U.S. Patent On Drone Positioning System
 
 
 
Upcoming Zoom Webinar
 

Join Zoom Meeting: zoom.us/j/97854930812
One tap mobile
US: +13126266799,,97854930812#,,,,*623264# or
+16465588656,,97854930812#,,,,*623264#
Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 978 5493 0812
Passcode: 623264
International numbers available:
zoom.us/u/ac33XYTF8


 
 
 

Join Zoom Meeting: zoom.us/j/95504618970
One tap mobile
US: +1 646 558 8656 or +1 301 715 8592 or +1 312 626 6799 or
+1 669 900 9128 or +1 253 215 8782 or +1 346 248 7799
Or Telephone:
Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 965 0895 7651
Passcode: 204541
International numbers available:
zoom.us/u/aPXCwm53A


 
 
 
 
 
 
 
Quote of the Week
 
"For me, the fun is to build, not to manage. I look for what's available, what is possible to do. That's the overriding consideration. There are a lot of things I would have liked to do, but didn't have the means."
- Dr. Phil Frost, Chairman OPKO Health
 
 
 
Lesson of the Week
 
Leadership makes or breaks companies.
Read More
 
 
 

 

Latest Videos
 
 
This Week on RedChip TV: 2 Transformative Small-Cap Stocks
 
This week’s episode of the RedChip Money Report features interviews with senior executives from Killi Ltd (OTCQB: MYIDD, TSX: MYID) and Virios (NASDAQ: VIRI).
 
Watch Now
 
 
 
 
DeFi Technologies: Transforming Global Finance
 
Led by co-founders Wouter Witvoet and Olivier Roussy Newton, who collectively raised $1.4B in their prior two deals, DeFi Technologies (OTC: RDNAF) is well positioned to become a key player in the rapidly growing decentralized finance industry. The market size for the industry is measured in the trillions and spans multiple sectors, including insurance, derivatives, credit and lending, asset management, and exchanges.
 
Watch Now
 
 
 
 
Virios Therapeutics: Potential Treatment Paradigm Shift for Fibromyalgia
 
Virios Therapeutics (Nasdaq: VIRI) is a clinical-stage biotechnology company focused on advancing novel, dual mechanism antiviral therapies to treat conditions associated with virally triggered or maintained immune responses, such as Fibromyalgia (“FM”).
 
Watch Now
 
 
 
 
Aptorum Group: Developing Novel Therapeutics for Unmet Medical Needs
 
Aptorum Group Limited (NASDAQ: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum's current drug pipeline includes indications in orphan diseases, infectious diseases, and metabolic diseases.
 
Watch Now
 
 
 
 
EVmo: Leading Provider of Rental Vehicles for the Gig Economy
 
EVmo (OTC: YAYO) bridges the gap between rideshare drivers in need of a suitable vehicle and rideshare companies that depend on attracting and keeping drivers. EVmo uniquely supports drivers in both the higher and lower economic categories with innovative policies and programs. EVmo is a leading provider of rental vehicles to drivers in the ever-expanding gig economy. EVmo maintains its own fleet of vehicles, which are rented to rideshare/delivery drivers, while providing insurance coverage and insurance cards in the drivers’ names to ensure drivers meet the stringent requirements of rideshare and logistics companies.
 
Watch Now
 
 
 
 
Killi: Transforming the $247B Market for Personal Data
 
Founded in 2018 and with offices in New York & Toronto, Killi (TSXV: MYID; OTCQB: MYIDD) is a company driven by the evolution of data and privacy. Killi aims to democratize data for consumers by providing them with an ecosystem where they can view, edit, opt-out, and be compensated for the use of their data. Today there is no destination for consumers to participate in the use of their data. Killi aspires to be the destination that consumers visit to reclaim control of their online data. Available on the web and in both the iOS and Google Play stores, Killi allows consumers to opt-in to share specific pieces of data with brands, agencies, and companies in exchange for compensation from the use of their personal data. All Killi data is first-party, global, and privacy complaint (CCPA/GDPR).
 
Watch Now
 
 
 
 
Elixinol: Industry Pioneer Set for Rapid Growth
 
Elixinol (OTC: ELLXF) is an original pioneer in the CBD industry — focused on the science, research and development of world-class cannabinoid products that provide real results for real people. A global company with a proven track record of growing and extracting premium-quality hemp, Elixinol's products are sold online at Elixinol.com, at over 2,600 natural, specialty and conventional grocery stores and pharmacies across the U.S., and around the world. Elixinol distributes CBD products in North and South America, throughout Europe, Asia and the Pacific Region under its own label, as well as bulk CBD and wholesale CBD.
 
Watch Now
 
 
 
 
BTCS: Pioneer in Blockchain Space
 
BTCS Inc. (OTCQB: BTCS) is an early entrant in the digital asset market and one of the first U.S. publicly traded companies focused on digital assets and blockchain technologies. BTCS resumed its transaction verification services business segment in the first quarter of 2021 with a focus on validating transactions and operating nodes on proof-of-stake blockchains.
 
Watch Now
 
 
 
 
DeFi Technologies: Transforming the Global Financial System
 
Led by co-founders Wouter Witvoet and Olivier Roussy Newton, who collectively raised $1.4B in their prior two deals, DeFi Technologies (OTC: RDNAF) is well positioned to become a key player in the rapidly growing decentralized finance industry. The market size for the industry is measured in the trillions and spans multiple sectors, including insurance, derivatives, credit and lending, asset management, and exchanges.
 
Watch Now
 
 
 
 
Learn Why Robert Blair, The Visionary Architect Behind Lulu Lemon (LULU) Joined RYU Apparel
 
RYU Apparel (OTCQB: RYPPF), or Respect Your Universe, is an award winning urban athletic apparel brand that engages in the development, marketing, and distribution of apparel, bags and accessories. Our products are engineered for the fitness, training and performance of the multi-discipline athlete. Our products are designed, developed and tested at our corporate headquarters in Vancouver, BC, Canada. Production takes place in factories located in North America and Asia.
 
Watch Now
 
 
 
 
Lantern Pharma: Transforming Cancer Drug Development with A.I.
 
Lantern Pharma (Nasdaq: LTNR) is a clinical stage biotechnology company leveraging its RADR® artificial intelligence (“A.I.”) platform to transform the pace, risk and cost of oncology drug development. RADR® A.I. quickly and efficiently develops precise genetic signatures of disease that underpin the identification of patients for whom its portfolio of oncology drug candidates is likely to have the greatest therapeutic effect. Lantern is currently developing three drug candidates in solid tumors.
 
Watch Now
 
 
 
 
Kiromic BioPharma: AI-Driven Immuno-Oncology Therapy Development
 
Kiromic BioPharma (Nasdaq: KRBP) is revolutionizing next-generation allogenic CAR therapies for solid tumors. The Company’s proprietary target discovery engine, Diamond uses AI and a proprietary neural network to identify development targets, dramatically compressing man years and billions of drug development dollars required to develop new live drugs.
 
Watch Now
 
 
 
 
Aridis Pharmaceuticals: Developing Novel Anti-Infective Therapies
 
Aridis Pharmaceuticals (Nasdaq: ARDS) discovers and develops anti-infectives to be used as add-on treatments to standard-of-care antibiotics. The Company is utilizing its proprietary ʎPEXTM and MabIgX® technology platforms to rapidly identify rare, potent antibody-producing B-cells from patients who have successfully overcome an infection, and to rapidly manufacture monoclonal antibody (mAbs) for therapeutic treatment of critical infections.
 
Watch Now
 
 
`
 
 
COMSovereign Corporate Overview with CEO & CTO
 
COMSovereign Holding (Nasdaq: COMS) Chairman & CEO Dan Hodges, along with Chief Technology Officer Dr. Dustin McIntire, share insight into the Company’s portfolio of communications technology companies and how they are expected to drive rapid growth in 2021 and beyond. Through strategic acquisitions and organic research and development efforts, COMSovereign has become a U.S.-based communications provider able to provide 4G LTE Advanced and 5G-NR telecom solutions to network operators and enterprises.
 
Watch Now
 
 
 
 
Hoth Therapeutics: Developing a New Generation of Therapies for Unmet Medical Needs
 
Hoth Therapeutics (Nasdaq: HOTH) is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. Hoth's clinical pipeline is concentrated on drug candidates that improve the quality of life for patients suffering from indications including atopic dermatitis, skin toxicities associated with cancer therapy, chronic wounds, psoriasis, asthma, acne, mast-cell derived cancers & anaphylaxis and pneumonia.
 
Watch Now
 
 
 
 
Can-Fite BioPharma: Advanced Clinical Stage Drug Development
 
Can-Fite BioPharma (NYSE American: CANF) has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory and cancer diseases. The company’s platform technology utilizes the Gi protein associated A3 adenosine receptor (A3AR) as a therapeutic target. A3AR is highly expressed in inflammatory and cancer cells where low expression is found in normal cells, suggesting that the receptor could be a unique target for pharmacological intervention.
 
Watch Now
 
 
 
 
Esports Entertainment Group CEO Discusses Plans for Rapid Growth
 
Interview with CEO of Esports Entertainment Group Inc. (NASDAQ: GMBL), a full stack esports and online gambling company fueled by the growth of video-gaming and the ascendance of esports with new generations. Its mission is to help connect the world at large with the future of sports entertainment in unique and enriching ways that bring fans and gamers together. Esports Entertainment Group and its affiliates are well-poised to help fans and players to stay connected and involved with their favorite esports.
 
Watch Now
 
 
 
 
Alset EHome International: Diversified Operations Accelerating Sustainable Healthy Living
 
Alset EHome International (Nasdaq: AEI) is a diversified holding company principally engaged through its subsidiaries in property development, digital transformation technology and biohealth activities with operations in the United States, Singapore, Hong Kong, Australia and South Korea.
 
Watch Now
 
 
 
 
CBD of Denver: Corporate Overview
 
CBD of Denver (OTC: CBDD) is a full-line CBD and hemp oil company, producing and distributing cannabis and CBD products in Switzerland, Europe, and the US. CBDD is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for its shareholders and is driven by a passion to improve lives and strengthen communities by unleashing the full potential of cannabis.
 
Watch Now
 
 
 
 
Nano Dimension: CEO Discusses Acquisition Strategy
 
Nano Dimension (NASDAQ: NNDM) is a provider of intelligent machines for the fabrication of Additively Manufactured Electronics (AME). High fidelity active electronic and electromechanical subassemblies are integral enablers of autonomous intelligent drones, cars, satellites, smartphones, and in vivo medical devices.
 
Watch Now
 
 
 
 
American Resources: Next-Generation Raw Materials Supplier for New Infrastructure
 
American Resources Corp. (Nasdaq: AREC) is a next-generation, environmentally and socially responsible supplier of high-quality raw materials to the new infrastructure market. The Company is focused on the extraction and processing of metallurgical carbon, an essential ingredient used in steelmaking, critical rare earth minerals for the electrification market, and reprocessed metal to be recycled.
 
Watch Now
 
 
 
 
Draganfly: Drone Technology Solving Real World Challenges
 
Draganfly (OTCQB: DFLYF) has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live.
 
Watch Now
 
 
 
 
Genetic Technologies: Innovative Tests to Determine Disease Risk
 
Genetic Technologies (Nasdaq: GENE) is a diversified molecular diagnostics company developing tools for the prediction and assessment of cancer risk to help physicians proactively manage patient health. The Company’s lead products, ‘GeneType for Breast Cancer’ and ‘GeneType for Colorectal Cancer’, are clinically validated risk assessment tests that are first in their class. The Company’s development pipeline includes new tests for COVID-19, Type 2 diabetes, cardiovascular disease, prostate cancer, and melanoma.
 
Watch Now
 
 
 
 
CBD of Denver: High-Growth Business Targeting US and Europe
 
CBD of Denver (OTC: CBDD) is a full-line CBD and hemp oil company, producing and distributing cannabis and CBD products in Switzerland, Europe, and the US. CBDD is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for its shareholders and is driven by a passion to improve lives and strengthen communities by unleashing the full potential of cannabis.
 
Watch Now
 
 
 
 
Amesite: Award-Winning AI-Driven Learning for Institution
 
Amesite (Nasdaq: AMST) is a high-tech artificial intelligence (AI) software company offering a cloud-based platform and content creation services for K-12, college, university and business education and upskilling. Amesite-offered courses and programs are branded to its customers.
 
Watch Now
 
 
 
 
BioVie: Developing Potential Game-Changing Treatments for Liver Disease
 
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing innovative drug therapies for liver disease. The Company’s drug candidate, BIV201 (continuous infusion terlipressin), has an Orphan Drug designation for the treatment of refractory ascites, FDA Fast Track status, and US patent pending. BIV201 also has an Orphan Drug designation for the treatment of hepatorenal syndrome (HRS).
 
Watch Now
 
 
 
 
Order Small Stocks, Big Money Today!
 
Dave Gentry is the author of Small Stocks, Big Money: Interviews With Microcap Superstars. Published by Wiley, this first-hand perspective on the fast world of microcap investing is now available for purchase.
 
 
MidSouth Week in Review
 
30-year mortgage rates declined for the second straight week to 3.04%, according to Freddie Mac.
Read More
 
 
 
 
About RedChip
 
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
 
RedChip Disclosure
 
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures.
 
 
     
 
 
Copyright © 2021 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.